![Gregory Chow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Chow
Director of Finance/CFO at
SUTRO BIOPHARMA, INC.
Net worth: 138 112 $ as of 2026-05-30
Profile
Gregory K.
Chow is Chief Financial & Accounting Officer at Sutro Biopharma, Inc. since 2025.
Formerly, Mr. Chow was Chief Financial & Business Officer at NodThera Ltd. from 2024 to 2025, Chief Financial Officer at Aptose Biosciences, Inc. from 2013 to 2021, Managing Director & Director-Private Placements at Wedbush Securities, Inc. from 2012 to 2013, Director-Private Placements at RBC Capital Markets, Inc. from 2006 to 2011, Chief Financial Officer at Freenome Holdings, Inc., Chief Financial Officer at Frontier Medicines Corp., and Senior Auditor at BDO USA PC from 1995 to 1998.
Education includes an undergraduate degree from the University of California, Santa Barbara in 1994 and an MBA from The Wharton School of the University of Pennsylvania in 2005.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-01 | 4,725 ( 0.03% ) | 138 112 $ | 2026-05-30 |
Gregory Chow active positions
| Companies | Position | Start |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Director of Finance/CFO | 2025-06-01 |
Former positions of Gregory Chow
| Companies | Position | End |
|---|---|---|
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Director of Finance/CFO | 2025-02-28 |
| APTOSE BIOSCIENCES INC. | Director of Finance/CFO | 2021-03-25 |
Wedbush Securities, Inc.
 Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Chief Executive Officer | 2012-12-31 |
RBC Capital Markets, Inc.
 RBC Capital Markets, Inc. Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 2010-12-31 |
BDO USA PC
 BDO USA PC Miscellaneous Commercial ServicesCommercial Services Provides assurance, tax and financial advisory services | Comptroller/Controller/Auditor | 1998-07-31 |
Training of Gregory Chow
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
87
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Aptose Biosciences, Inc.
 Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
BDO USA PC
BDO USA PC Miscellaneous Commercial ServicesCommercial Services Provides assurance, tax and financial advisory services | Commercial Services |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets, Inc.
RBC Capital Markets, Inc. Investment ManagersFinance Provides investment advice | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Freenome Holdings, Inc.
 Freenome Holdings, Inc. Medical SpecialtiesHealth Technology Operates as an early cancer detection company that develops blood-based screening tests | Health Technology |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Develops medicines that redefine the course of debilitating diseases | Health Technology |
- Stock Market
- Insiders
- Gregory Chow
